1 Result

People

  1. Abou-Alfa
    Abou-Alfa
  2. Capanu
    Capanu
  3. Chou
    Chou
  4. Do
    Do
  5. El Dika
    El Dika
  6. Harding
    Harding
  7. Hrabovsky
    Hrabovsky
  8. Ly
    Ly
  9. Ma
    Ma
  10. Millang
    Millang

Groups

  1. Biostatistics Service (1)
  2. Body Imaging Service (1)
  3. Center for Pancreatic Cancer Research (1)
  4. Department of Medicine (1)
  5. Department of Pathology and Laboratory Medicine (1)
  6. Epidemiology and Biostatistics (1)
  7. GME, Radiation Oncology (1)
  8. Gastrointestinal Oncology Service (1)
  9. Graduate Medical Education (1)
  10. Radiation Oncology, Department of (1)
  1. "ask-1"
Formats
  1. Journal Article (1)
Groups
  1. Biostatistics Service (1)
  2. Body Imaging Service (1)
  3. Center for Pancreatic Cancer Research (1)
  4. Department of Medicine (1)
  5. Department of Pathology and Laboratory Medicine (1)
  6. Epidemiology and Biostatistics (1)

More Groups

People
  1. Anna Hrabovsky (1)
  2. Brittanie Millang (1)
  3. Eileen O'Reilly (1)
  4. Ghassan Abou-Alfa (1)
  5. Imane El Dika (1)
  6. James Harding (1)

More People

Years
  1. 2020 (1)
Publications
  1. Cancer Medicine (1)
Publishers
  1. Wiley Blackwell (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib
    Journal Article

    El Dika, I.; Capanu, M.; Chou, J. F.; Harding, J. J.; Ly, M.; Hrabovsky, A. D.; Do, R. K. G.; Shia, J.; Millang, B.; Ma, J.; more...
    Cancer Medicine (2020)

    Fulltext@MSK | Save